First clinical trial with a device on anaphylaxis management

Randomized, open and cross-over clinical trial to evaluate the satisfaction of a medical device’s prototype (Smart case for epinephrine autoinjector + APP) for the management of anaphylaxis.

It is the first clinical trial with a medical device’s prototype and app that evaluates its usefulness for the management of anaphylaxis

100 patients were randomized and 95 patients finalized the study in one of the largest hospitals in Europe (Tertiary University Hospital Vall d’Hebron).

Adherence, anxiety, satisfaction and usability were recorded and analysed.

Finished in May 2017. 

To see the abstract of the results, please visit

Paper’s publication with final results coming soon.